Isabelle Cacciapuoti

Isabelle Cacciapuoti

Auto-generated profile, based on publicly available information

Isabelle Cacciapuoti

Inovarion 2 , Paris 75005, France

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2015 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
PMPhilippe Menasché
Philippe Menasché
VVValérie Vanneaux
Valérie Vanneaux
AHAlbert Hagege
Albert Hagege
ABAlain Bel
Alain Bel
BCBernard CHOLLEY
Bernard CHOLLEY
JLJérôme Larghero
Jérôme Larghero
Aims Comparative studies suggest that stem cells committed to a cardiac lineage are more effective for improving heart function than those featuring an extra-cardiac phenotype. We have therefore developed a population of human embryonic stem cell (ESC)-derived cardiac progenitor cells. Methods and results Undifferentiated human ESCs (I6 line) were amplified and cardiac-committed by exposure to bone morphogenetic protein-2 and a fibroblast growth factor receptor inhibitor. Cells responding to these cardio-instructive cues express the cardiac transcription factor Isl-1 and the stage-specific embryonic antigen SSEA-1 which was then used to purify them by immunomagnetic sorting. The Isl-1 + SSEA-1+ cells were then embedded into a fibrin scaffold which was surgically delivered onto the infarct area in a 68-year-old patient suffering from severe heart failure [New York Heart Association [NYHA] functional Class III; left ventricular ejection fraction (LVEF): 26%]. A coronary artery bypass was performed concomitantly in a non-infarcted area. The implanted cells featured a high degree of purity (99% were SSEA-1+), had lost the expression of Sox-2 and Nanog , taken as markers for pluripotency, and strongly expressed Isl-1 . The intraoperative delivery of the patch was expeditious. The post-operative course was uncomplicated either. After 3 months, the patient is symptomatically improved (NYHA functional Class I; LVEF: 36%) and a new-onset contractility is echocardiographically evident in the previously akinetic cell/patch-treated, non-revascularized area. There have been no complications such as arrhythmias, tumour formation, or immunosuppression-related adverse events. Conclusion This observation demonstrates the feasibility of generating a clinical-grade population of human ESC-derived cardiac progenitors and combining it within a tissue-engineered construct. While any conclusion pertaining to efficacy would be meaningless, the patient's functional outcome yet provides an encouraging hint. Beyond this case, the platform that has been set could be useful for generating different ESC-derived lineage-specific progenies.

1 January 2018 in JACC
Verified
Journal Article
Closed access
PMPhilippe Menasché
Philippe Menasché
VVValérie Vanneaux
Valérie Vanneaux
AHAlbert Hagège
Albert Hagège
ABAlain Bel
Alain Bel
BCBernard CHOLLEY
Bernard CHOLLEY
JLJérôme Larghero
Jérôme Larghero

1 June 2016 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
AKAnaïs Kervadec
Anaïs Kervadec
VBValérie Bellamy
Valérie Bellamy
NHNadia El Harane
Nadia El Harane
LALousineh Arakélian
Lousineh Arakélian
VVValérie Vanneaux
Valérie Vanneaux
NRNisa K.E. Renault
Nisa K.E. Renault

1 November 2020 in Biointerphases
Verified
Journal Article
Closed access
PDF file
ALAmélie Leroux
Amélie Leroux
TNTuan Ngoc Nguyen
Tuan Ngoc Nguyen
ARAndré RANGEL
André RANGEL
ICIsabelle Cacciapuoti
Isabelle Cacciapuoti
DDDelphine DUPREZ
Delphine DUPREZ
VMVéronique Migonney
Véronique Migonney
Polycaprolactone (PCL) is a widely used biodegradable polyester for tissue engineering applications when long-term degradation is preferred. In this article, we focused on the analysis of the hydrolytic degradation of virgin and bioactive poly(sodium styrene sulfonate) (pNaSS) functionalized PCL surfaces under simulated physiological conditions (phosphate buffer saline at 25 and 37 °C) for up to 120 weeks with the aim of applying bioactive PCL for ligament tissue engineering. Techniques used to characterize the bulk and surface degradation indicated that PCL was hydrolyzed by a bulk degradation mode with an accelerated degradation—three times increased rate constant—for pNaSS grafted PCL at 37 °C when compared to virgin PCL at 25 °C. The observed degradation mechanism is due to the pNaSS grafting process (oxidation and radical polymerization), which accelerated the degradation until 48 weeks, when a steady state is reached. The PCL surface was altered by pNaSS grafting, introducing hydrophilic sulfonate groups that increase the swelling and smoothing of the surface, which facilitated the degradation. After 48 weeks, pNaSS was largely removed from the surface, and the degradation of virgin and pNaSS grafted surfaces was similar. The cell response of primary fibroblast cells from sheep ligament was consistent with the surface analysis results: a better initial spreading of cells on pNaSS surfaces when compared to virgin surfaces and a tendency to become similar with degradation time. It is worthy to note that during the extended degradation process the surfaces were able to continue inducing better cell spreading and preserve their cell phenotype as shown by collagen gene expressions.

1 January 2020 in Biology Open
Verified
Journal Article
Open access
PDF file
LGLudovic Gaut
Ludovic Gaut
MBMarie-Ange Bonnin
Marie-Ange Bonnin
CBCédrine Blavet
Cédrine Blavet
ICIsabelle Cacciapuoti
Isabelle Cacciapuoti
MOMonika Orpel
Monika Orpel
DDDelphine DUPREZ
Delphine DUPREZ
One of the main challenges relating to tendons is to understand the regulators of the tendon differentiation program. The optimum culture conditions that favor tendon cell differentiation have not been identified. Mesenchymal stem cells present the ability to differentiate into multiple lineages in cultures under different cues ranging from chemical treatment to physical constraints. We analyzed the tendon differentiation potential of C3H10T1/2 cells, a murine cell line of mesenchymal stem cells, upon different 2D- and 3D-culture conditions. We observed that C3H10T1/2 cells cultured in 2D conditions on silicone substrate were more prone to tendon differentiation, assessed with the expression of the tendon markers Scx, Col1a1 and Tnmd as compared to cells cultured on plastic substrate. The 3D-fibrin environment was more favorable for Scx and Col1a1 expression compared to 2D cultures. We also identified TGFβ2 as a negative regulator of Tnmd expression in C3H10T1/2 cells in 2D and 3D cultures. Altogether, our results provide us with a better understanding of the culture conditions that promote tendon gene expression and identify mechanical and molecular parameters upon which we could act to define the optimum culture conditions that favor tenogenic differentiation in mesenchymal stem cells.